MET ALTERATION

Clinical trials for MET ALTERATION explained in plain language.

Never miss a new study

Get alerted when new MET ALTERATION trials appear

Sign up with your email to follow new studies for MET ALTERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug cocktail aims to outsmart lung cancer resistance

Disease control Not yet recruiting

This study tests a new drug combination for people with advanced lung cancer that has a specific gene change (EGFR mutation). The experimental drug ANS014004 is designed to block a protein that often makes tumors stop responding to standard targeted therapy. The trial will first …

Matched conditions: MET ALTERATION

Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated Jun 16, 2026 12:49 UTC

MET ALTERATION

Get alerted when new MET ALTERATION trials appear

New drug cocktail aims to outsmart lung cancer resistance